JIN MEDICAL INTERNATIONAL LT (ZJYL) Stock Fundamental Analysis

NASDAQ:ZJYL • KYG5140V1124

0.1471 USD
-0.01 (-7.43%)
Last: Feb 12, 2026, 02:55 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, ZJYL scores 4 out of 10 in our fundamental rating. ZJYL was compared to 186 industry peers in the Health Care Equipment & Supplies industry. ZJYL has an excellent profitability rating, but there are some minor concerns on its financial health. ZJYL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • ZJYL had positive earnings in the past year.
  • ZJYL had a positive operating cash flow in the past year.
  • Each year in the past 5 years ZJYL has been profitable.
  • ZJYL had a positive operating cash flow in 4 of the past 5 years.
ZJYL Yearly Net Income VS EBIT VS OCF VS FCFZJYL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

1.2 Ratios

  • With an excellent Return On Assets value of 3.69%, ZJYL belongs to the best of the industry, outperforming 80.11% of the companies in the same industry.
  • The Return On Equity of ZJYL (6.42%) is better than 80.11% of its industry peers.
  • With a decent Return On Invested Capital value of 3.84%, ZJYL is doing good in the industry, outperforming 72.04% of the companies in the same industry.
  • ZJYL had an Average Return On Invested Capital over the past 3 years of 9.49%. This is in line with the industry average of 8.83%.
  • The last Return On Invested Capital (3.84%) for ZJYL is well below the 3 year average (9.49%), which needs to be investigated, but indicates that ZJYL had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.69%
ROE 6.42%
ROIC 3.84%
ROA(3y)9.9%
ROA(5y)10.46%
ROE(3y)14.18%
ROE(5y)16.34%
ROIC(3y)9.49%
ROIC(5y)11.9%
ZJYL Yearly ROA, ROE, ROICZJYL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • With an excellent Profit Margin value of 7.85%, ZJYL belongs to the best of the industry, outperforming 80.65% of the companies in the same industry.
  • ZJYL's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 8.57%, ZJYL is in the better half of the industry, outperforming 76.88% of the companies in the same industry.
  • ZJYL's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 35.79%, ZJYL is not doing good in the industry: 72.04% of the companies in the same industry are doing better.
  • ZJYL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.57%
PM (TTM) 7.85%
GM 35.79%
OM growth 3Y6.9%
OM growth 5Y-6.46%
PM growth 3Y7.26%
PM growth 5Y-2.67%
GM growth 3Y9.69%
GM growth 5Y1.86%
ZJYL Yearly Profit, Operating, Gross MarginsZJYL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZJYL is creating some value.
  • ZJYL has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ZJYL has been reduced compared to 5 years ago.
  • The debt/assets ratio for ZJYL is higher compared to a year ago.
ZJYL Yearly Shares OutstandingZJYL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ZJYL Yearly Total Debt VS Total AssetsZJYL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • An Altman-Z score of 2.55 indicates that ZJYL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ZJYL has a Altman-Z score of 2.55. This is in the better half of the industry: ZJYL outperforms 69.89% of its industry peers.
  • ZJYL has a Debt/Equity ratio of 0.56. This is a neutral value indicating ZJYL is somewhat dependend on debt financing.
  • ZJYL has a Debt to Equity ratio of 0.56. This is in the lower half of the industry: ZJYL underperforms 60.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Altman-Z 2.55
ROIC/WACC0.46
WACC8.31%
ZJYL Yearly LT Debt VS Equity VS FCFZJYL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • ZJYL has a Current Ratio of 2.11. This indicates that ZJYL is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 2.11, ZJYL perfoms like the industry average, outperforming 41.94% of the companies in the same industry.
  • ZJYL has a Quick Ratio of 1.90. This is a normal value and indicates that ZJYL is financially healthy and should not expect problems in meeting its short term obligations.
  • ZJYL has a Quick ratio of 1.90. This is comparable to the rest of the industry: ZJYL outperforms 51.61% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.9
ZJYL Yearly Current Assets VS Current LiabilitesZJYL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • ZJYL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.04%.
  • The Earnings Per Share has been growing slightly by 3.28% on average over the past years.
  • The Revenue has grown by 13.42% in the past year. This is quite good.
  • Measured over the past years, ZJYL shows a small growth in Revenue. The Revenue has been growing by 2.90% on average per year.
EPS 1Y (TTM)-39.04%
EPS 3Y5.52%
EPS 5Y3.28%
EPS Q2Q%-105.22%
Revenue 1Y (TTM)13.42%
Revenue growth 3Y4.22%
Revenue growth 5Y2.9%
Sales Q2Q%-6.4%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZJYL Yearly Revenue VS EstimatesZJYL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.71 indicates a correct valuation of ZJYL.
  • Based on the Price/Earnings ratio, ZJYL is valued cheaply inside the industry as 88.71% of the companies are valued more expensively.
  • ZJYL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.18.
Industry RankSector Rank
PE 14.71
Fwd PE N/A
ZJYL Price Earnings VS Forward Price EarningsZJYL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -11.75
ZJYL Per share dataZJYL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

  • The decent profitability rating of ZJYL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.49
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ZJYL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

JIN MEDICAL INTERNATIONAL LT

NASDAQ:ZJYL (2/12/2026, 2:55:14 PM)

0.1471

-0.01 (-7.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.14%
Inst Owner Change-16.57%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.03M
Revenue(TTM)22.83M
Net Income(TTM)1.79M
AnalystsN/A
Price TargetN/A
Short Float %0.43%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.71
Fwd PE N/A
P/S 1.01
P/FCF N/A
P/OCF 17.65
P/B 0.83
P/tB 0.86
EV/EBITDA -11.75
EPS(TTM)0.01
EY6.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.01
OCFY5.67%
SpS0.15
BVpS0.18
TBVpS0.17
PEG (NY)N/A
PEG (5Y)4.49
Graham Number0.2
Profitability
Industry RankSector Rank
ROA 3.69%
ROE 6.42%
ROCE 7.04%
ROIC 3.84%
ROICexc 13.32%
ROICexgc 14.59%
OM 8.57%
PM (TTM) 7.85%
GM 35.79%
FCFM N/A
ROA(3y)9.9%
ROA(5y)10.46%
ROE(3y)14.18%
ROE(5y)16.34%
ROIC(3y)9.49%
ROIC(5y)11.9%
ROICexc(3y)22.47%
ROICexc(5y)22.7%
ROICexgc(3y)23.46%
ROICexgc(5y)23.49%
ROCE(3y)12.88%
ROCE(5y)15.84%
ROICexgc growth 3Y-2.39%
ROICexgc growth 5Y-7.19%
ROICexc growth 3Y-4.58%
ROICexc growth 5Y-8.54%
OM growth 3Y6.9%
OM growth 5Y-6.46%
PM growth 3Y7.26%
PM growth 5Y-2.67%
GM growth 3Y9.69%
GM growth 5Y1.86%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Debt/EBITDA 7.13
Cap/Depr 847.75%
Cap/Sales 9.25%
Interest Coverage 5.51
Cash Conversion 59.19%
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 1.9
Altman-Z 2.55
F-Score4
WACC8.31%
ROIC/WACC0.46
Cap/Depr(3y)178.09%
Cap/Depr(5y)117.95%
Cap/Sales(3y)1.86%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.04%
EPS 3Y5.52%
EPS 5Y3.28%
EPS Q2Q%-105.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.42%
Revenue growth 3Y4.22%
Revenue growth 5Y2.9%
Sales Q2Q%-6.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.9%
EBIT growth 3Y11.4%
EBIT growth 5Y-3.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.18%
OCF growth 3YN/A
OCF growth 5YN/A

JIN MEDICAL INTERNATIONAL LT / ZJYL FAQ

Can you provide the ChartMill fundamental rating for JIN MEDICAL INTERNATIONAL LT?

ChartMill assigns a fundamental rating of 4 / 10 to ZJYL.


What is the valuation status for ZJYL stock?

ChartMill assigns a valuation rating of 2 / 10 to JIN MEDICAL INTERNATIONAL LT (ZJYL). This can be considered as Overvalued.


What is the profitability of ZJYL stock?

JIN MEDICAL INTERNATIONAL LT (ZJYL) has a profitability rating of 7 / 10.


Can you provide the financial health for ZJYL stock?

The financial health rating of JIN MEDICAL INTERNATIONAL LT (ZJYL) is 4 / 10.